EYPT Q1 2018 Earnings — EyePoint Pharmaceuticals, Inc. Revenue & Financial Results | Market Cap Arena

EYPTEyePoint Pharmaceuticals, Inc.

$1B

Q1 2018 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$928,000+57.3% YoY

Gross Profit

-$2M-258.3% margin

Operating Income

-$5M-504.1% margin

Net Income

-$7M-751.9% margin

EPS (Diluted)

$-1.53

QoQ Revenue Growth

-0.5%

Cash Flow

Operating Cash Flow

-$5M

Free Cash Flow

-$5M

Stock-Based Comp.

$443,000

Balance Sheet

Total Assets

$50M

Total Liabilities

$42M

Stockholders' Equity

$8M

Cash & Equivalents

$16M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$928,000	$590,000	+57.3%
Gross Profit	-$2M	-$3M	+12.3%
Operating Income	-$5M	-$5M	+9.3%
Net Income	-$7M	-$5M	-35.8%